ADNP and ovarian carcinoma: ADNP is important for cell signalling and cancer growth and has been suggested as a potential as a biomarker and / or therapeutic target for gastric and colorectal cancer, hepatocellular carcinoma, glioblastoma multiforme, Bladder cancer, ovarian cancer, and breast cancer.